Capital Investment Advisory Services, LLC Astrazeneca PLC Transaction History

Capital Investment Advisory Services, LLC

$972 Million
Q4 2024

A detailed history of Capital Investment Advisory Services, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital Investment Advisory Services, LLC holds 3,321 shares of AZN stock, worth $247,248. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,321

Previous 4,527 26.64%

Holding current value

$247,248

Previous $352,000 38.35%

% of portfolio

0.02%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$63.2 - $79.58 $76,219 - $95,973	-1,206 Reduced 26.64%	3,321 $217,000
Q3 2024 Oct 30, 2024	SELL	$76.67 - $87.62 $1,380 - $1,577	-18 Reduced 0.4%	4,527 $352,000
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $3,273 - $3,960	49 Added 1.09%	4,545 $354,000
Q1 2024 Apr 25, 2024	SELL	$61.03 - $69.57 $69,085 - $78,753	-1,132 Reduced 20.11%	4,496 $304,000
Q4 2023 Feb 01, 2024	SELL	$61.89 - $69.28 $85,160 - $95,329	-1,376 Reduced 19.65%	5,628 $379,000
Q3 2023 Nov 02, 2023	BUY	$64.85 - $71.7 $91,697 - $101,383	1,414 Added 25.3%	7,004 $474,000
Q2 2023 Jul 28, 2023	SELL	$69.91 - $75.81 $23,909 - $25,927	-342 Reduced 5.77%	5,590 $400,000
Q1 2023 Apr 21, 2023	SELL	$63.15 - $71.6 $24,628 - $27,923	-390 Reduced 6.17%	5,932 $411,000
Q4 2022 Feb 03, 2023	SELL	$54.21 - $70.44 $64,672 - $84,034	-1,193 Reduced 15.87%	6,322 $428,000
Q3 2022 Oct 26, 2022	SELL	$53.02 - $135.75 $10,126 - $25,928	-191 Reduced 2.48%	7,515 $412,000
Q2 2022 Jul 22, 2022	BUY	$59.26 - $71.14 $20,029 - $24,045	338 Added 4.59%	7,706 $509,000
Q1 2022 May 03, 2022	SELL	$55.72 - $67.12 $58,394 - $70,341	-1,048 Reduced 12.45%	7,368 $489,000
Q4 2021 Feb 01, 2022	SELL	$54.02 - $63.83 $15,287 - $18,063	-283 Reduced 3.25%	8,416 $490,000
Q3 2021 Oct 28, 2021	SELL	$55.56 - $60.79 $389,420 - $426,077	-7,009 Reduced 44.62%	8,699 $522,000
Q2 2021 Jul 27, 2021	SELL	$48.42 - $60.18 $246,603 - $306,496	-5,093 Reduced 24.48%	15,708 $941,000
Q1 2021 May 05, 2021	SELL	$47.16 - $54.44 $353,841 - $408,463	-7,503 Reduced 26.51%	20,801 $1.03 Million
Q4 2020 Jan 25, 2021	SELL	$48.52 - $58.02 $1,115 - $1,334	-23 Reduced 0.08%	28,304 $1.42 Million
Q3 2020 Oct 19, 2020	BUY	$53.07 - $61.1 $5,253 - $6,048	99 Added 0.35%	28,327 $1.55 Million
Q2 2020 Aug 05, 2020	BUY	$43.1 - $55.31 $3,965 - $5,088	92 Added 0.33%	28,228 $1.49 Million
Q1 2020 Apr 28, 2020	BUY	$37.79 - $51.33 $1.06 Million - $1.44 Million	28,136 New	28,136 $1.26 Million
Q4 2019 Feb 04, 2020	SELL	$42.46 - $50.46 $120,586 - $143,306	-2,840 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$40.12 - $45.47 $5,616 - $6,365	140 Added 5.19%	2,840 $127,000
Q2 2019 Aug 08, 2019	BUY	$37.28 - $41.68 $18,640 - $20,840	500 Added 22.73%	2,700 $109,000
Q4 2018 Feb 04, 2019	BUY	$36.86 - $41.49 $81,092 - $91,278	2,200 New	2,200 $84,000

Others Institutions Holding AZN

# of Institutions

1,343

Shares Held

477M

Call Options Held

5.29M

Put Options Held

3.79M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $231B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.

Account

Capital Investment Advisory Services, LLC Astrazeneca PLC Transaction History